Phase I/II Clinical Trials Prostate Cancer

Clinical Trial SP015 (Eudra CT: 2015-004314-15) is a Phase I/II, single-arm clinical trial to evaluate the safety and immune activation of the combination of DCVAC/PCa, an active cellular immunotherapy, and ONCOS-102, an immune-priming adenovirus, in men with advanced metastatic castration-resistant prostate cancer. This clinical trial has started in May 2018. The planned number of patients enrolled is up to 15. For more information visit .

Only a physician conducting a clinical evaluation of an investigational treatment SOTIO® DCVAC/PCa can include a patient in a clinical trial. If a patient with prostate cancer would like to participate in a trial he can contact participating medical center.

List of participating Medical Centers
Medical Center Address Department Clinical Trial Number
Fakultní nemocnice v Motole V Úvalu 84
Praha 5
150 06
Czech Republic
Urology Clinic of Charles University's Second Faculty of Medicine and Motol University Hospital SP015

We use cookies to give you the best possible experience on our website. More information